Access to Medicines Foundation on AMR

The Access to Medicine Foundation seeks to utilize an initial instalment of €200,000 from the Wellcome Trust to jumpstart the following work with their AMR programme: (1) finalise and publish the Foundation’s first ever deep-dive thematic study on responsible manufacturing of antibiotics, with an aim to shed light on critical issues relevant to G20 2023 discussions; (2) longitudinally assess and encourage further company progress through a publication on the opportunities identified in the 2021 AMR Benchmark; (3) deepen relationships and engagement work with antibiotic manufacturers, global health stakeholders, and governments in order to take steps towards creating a dependable accountability framework for manufacturing stewardship; (4) commence work on a thematic study on R&D for antibiotics, antifungals and diagnostic products as well as planning for related engagement activities to advance stakeholder alignment towards the 2024 high-level UNGA meeting on AMR. This generous funding will serve as a crucial seed for the AMR programme work and empower the Foundation to continue leading the charge when it comes to holding industry accountability for curbing AMR.